Exploring the “Drug–Syndrome–Disease” Triad Association Therapy in the Intervention of Western Drug Toxic Side Effects: Theory and Practice Based on the Compound 511

Abstract Addressing the clinical challenge of toxic side effects of Western drugs represented by drug addiction (e.g., opioids, nicotine), this paper aims to propose and elucidate a new integrated intervention paradigm based on the “drug–syndrome–disease” triad association, exploring comprehensive solutions using Chinese herbal formulas to target Western pathologies and systematically regulate traditional Chinese medicine (TCM) syndromes. Using the Compound 511 as an example, we first systematically review the Western pathology of opioid addiction, focusing on abnormalities in the reward circuit (nucleus accumbens NAc-ventral tegmental area VTA) and neuroadaptive changes mediated by key transcription factors like delta FosB (ΔFosB). Subsequently, we analyze its corresponding TCM pathogenesis evolution pattern centered on “imbalance of body and spirit” and “deficiency of both qi and yin.” Based on this, we deconstruct how Compound 511 achieves precise compatibility following the “drug–syndrome–disease” logic. The Compound 511 embodies the precise compatibility of “simultaneous treatment of disease and syndrome”: Herbs like Yangjinhua (Daturae Flos) and Yanhusuo (Corydalis Rhizoma) as targeting drugs directly address the core pathological “disease” states such as neural agitation during withdrawal; herbs like Renshen (Ginseng Radix et Rhizoma), Huangqi (Astragali Radix), and Maidong (Ophiopogonis Radix) as regulating herbs correct the “syndrome” of “qi and yin deficiency” during the rehabilitation phase; assisted by multitarget regulating herbs like Jiaogulan (Gynostemmae Herba). Modern research confirms that this formula can modulate the NAc histone H3 lysine 9 dimethylation (H3K9me2)/ΔFosB signaling pathway, reverse abnormal synaptic plasticity, achieving “toxicity reduction and efficacy enhancement.” The “drug–syndrome–disease” triad association therapy organically combines “targeting drugs based on pathological differentiation” and “regulating the holistic syndrome based on stage differentiation,” constituting a systematic, integrated Chinese–Western medical approach and clinical paradigm for intervening in iatrogenic dependence and chronic drug-induced damage.